Moderna COVID-19 Vaccine Summary | Vaccines & Immunizations …
Aug 28, 2024 · Moderna COVID-19 Vaccine 2024-2025 Formula is indicated for people 6 months through 11 years of age. Moderna SPIKEVAX ® is indicated for people 12 years and older
Moderna COVID-19 Vaccine | FDA
Nov 4, 2024 · The Moderna COVID-19 Vaccine (2024-2025 Formula) is authorized for all doses administered to individuals 6 months through 11 years of age to prevent COVID-19.
Moderna COVID-19 vaccine - Wikipedia
The Moderna COVID‑19 vaccine, sold under the brand name Spikevax, is a COVID-19 vaccine developed by the American company Moderna, the United States National Institute of Allergy and Infectious Diseases (NIAID), and the Biomedical Advanced …
Moderna COVID-19 Vaccine At-A-Glance Guidance below summarizes basic storage, preparation, scheduling, administration, and dosage for all 2024–25 Moderna COVID-19 vaccine products. Distributed in: Ages: 6 months through 11 years Manufacturer-filled syringe Ages: 12 years and older Manufacturer-filled syringe Storage and Handling
Staying Up to Date with COVID-19 Vaccines | COVID-19 | CDC
Jan 7, 2025 · Learn more about the benefits of getting a COVID-19 vaccine. When are you up to date? Your child is up to date when they have received all recommended doses, including at least 1 dose of the 2024–2025 COVID-19 vaccine. 1 dose of …
FDA Approves and Authorizes Updated mRNA COVID-19 Vaccines …
Today, the U.S. Food and Drug Administration approved and granted emergency use authorization (EUA) for updated mRNA COVID-19 vaccines (2024-2025 formula) to include a monovalent (single)...
The Moderna COVID-19 (mRNA-1273) vaccine: what you need …
Aug 18, 2022 · For adults aged 17 and above, SAGE recommends the use of the Moderna mRNA-1273 vaccine at a schedule of two doses (100 µg, 0.5 ml each) 8 weeks apart. For adolescents aged 12 to 17 years, SAGE recommends 2 doses (100 µg, 0.5 ml each), given intramuscularly, 4 weeks apart.
Celebrating U.S. FDA Approval of Our Updated COVID-19 Vaccine - Moderna
I am pleased to announce that the U.S. Food and Drug Administration (FDA) has approved Moderna’s updated COVID-19 vaccine for this fall for individuals 12 years of age and older. The updated vaccine composition targets the KP.2 variant, based on guidance from the U.S. FDA.
Moderna COVID-19 Vaccine is a vaccine for use in individuals 6 months through 11 years of age to prevent COVID-19. The FDA has authorized the emergency use of Moderna COVID-19
The Moderna COVID-19 Vaccine is a vaccine and may prevent you from getting COVID-19. There is no U.S. Food and Drug Administration (FDA) approved vaccine to prevent COVID-19. Read this Fact Sheet for information about the Moderna COVID-19 Vaccine.